Correction to: Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer

Affiliations

• ¹ Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
• ² Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
• ³ Nanjing Blue Shield Biotechnology Co., Ltd., Nanjing, 210023, China.
• ⁴ Department of Pathology, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
• ⁵ Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
• ⁶ Inner Mongolia Autonomous Region Cancer Hospital, Hohhot, 010010, China.
• ⁷ Baylor University, 1311 S 5Th St, Waco, USA.
• ⁸ Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China. huzg_2000@126.com.
• ⁹ Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China. guo@njnu.edu.cn.